Format

Send to

Choose Destination
J Hepatol. 2018 Mar;68(3):595-597. doi: 10.1016/j.jhep.2017.09.019. Epub 2017 Oct 4.

Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world.

Author information

1
Laboratoire Alphabio, Marseille, France; Hôpital Européen, Marseille, France. Electronic address: philippe.halfon@alphabio.fr.
2
CHU Lyon, Lyon, France.
3
CHU Toulouse Purpan, Toulouse, France.
4
CHU Grenoble Alpes, Grenoble, France.
5
CHU Bordeaux, Bordeaux, France.
6
CHU Toulouse Purpan, UMR 152 IRD Toulouse 3, Toulouse, France.
7
Hôpital Michallon, Grenoble, France.
8
Institut Arnault Tzanck, Saint Laurent du Var, France.
9
Hôpital Haut-Lévêque, CHU Bordeaux, Pessac, France.
10
Laboratoire Alphabio, Marseille, France.
11
Hôpital Européen, Marseille, France.
12
Hôpital Saint-Joseph, Marseille, France.
PMID:
28987520
DOI:
10.1016/j.jhep.2017.09.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center